Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

A novel protein therapy for efficient skin wound healing

A group of researchers at A*STAR’s (Agency for...

Principal causes for hospital readmission identified

A group of physicians in Canada examined a...

COVID-19 may promote the spread of drug-resistant ‘superfungus’

Medical News Today recently reported on an...

National Diabetes Foot Care Report

National Diabetes Foot Care Report The National...

US hospitals lost $22.3B delaying elective surgeries, study estimates

As a result of the pandemic, a study shared by...

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Global burden of bacterial antimicrobial...

Webinar: Local Antibiotic Carrier for the Management of Spine Infections

Tema   Webinar: Local Antibiotic Carrier...

Audio Interview: Building a Successful Public Health Response to Covid-19

The continuing spread of SARS-CoV-2 remains a...

Displasia osteofibrosa de tibia: reporte de caso

La displasia osteofibrosa...

Distribuidor exclusivo.

0